SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001410578-23-001458
Filing Date
2023-06-23
Accepted
2023-06-23 11:44:38
Documents
63
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q/A tmb-20230228x10qa.htm   iXBRL 10-Q/A 1420917
  Complete submission text file 0001410578-23-001458.txt   6998777

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20230228.xsd EX-101.SCH 66083
3 EX-101.CAL tmb-20230228_cal.xml EX-101.CAL 34750
4 EX-101.DEF tmb-20230228_def.xml EX-101.DEF 242298
5 EX-101.LAB tmb-20230228_lab.xml EX-101.LAB 481568
6 EX-101.PRE tmb-20230228_pre.xml EX-101.PRE 354835
57 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230228x10qa_htm.xml XML 1269636
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q/A | Act: 34 | File No.: 000-55535 | Film No.: 231036123
SIC: 2834 Pharmaceutical Preparations